Agilent unveils SureSelect DNA kit

January 28, 2020 -- Agilent Technologies has debuted SureSelect XT HS2, a DNA kit designed to help laboratories prepare DNA sequencing libraries for cancer and genetics research.

SureSelect XT HS2 enables the ability to multiplex hundreds of samples in one sequencing run and facilitates the removal of sample contamination due to index hopping from reads, according to the firm.

In addition, the kit features better error correction for detecting variants with low allele frequencies and the option to purchase solid-phase reversible immobilization (SPRI) beads and streptavidin beads as part of a complete kit, Agilent said.

Software improves compatibility and efficiency in chromatography
On January 2, Thermo Fisher Scientific and Agilent Technologies announced their continued agreement to the industry-wide Instrument Control Exchange Program...

Copyright © 2020

Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter